Lead ink fragrance
Release time:
2022-04-06
■ Daye Peak Wang Yiyan
When he was at school, he read the collection of Lu Xun's "Scream" novels, understood the novel's profound analysis of the old system and social contradictions, and moved Yu's awareness of national survival and his strong desire for social change. At that time, I childishly thought that Mr. Lu Xun could produce a collection of novels to shout for the country and the people. If we little people can occasionally publish some small articles in the newspaper to express our feelings, it is indeed a carefree thing.
In high school, the student union set up a student poetry club "Luming Garden " . At that time, writers such as Zhang Xiaofeng and Xi Murong were very popular and wrote two articles in imitation. They were actually moaning without illness and felt meaningless. Later, they were busy studying, so they lost their energy. After taking part in the work, I sometimes felt it and wrote one or two short essays. I had the urge to submit articles to the newspaper. I always felt that I couldn't take it and let it go. After all, the articles didn't survive. I succumbed to wealth, rice, oil and salt, and the literary dream slowly woke up.
In 2007 , I joined Daye Peak with my wife. In , 2008 , it coincided with the 18th anniversary of the start-up of Jianfeng Group 50#. The Peak News launched a solicitation campaign and department leaders mobilized employees to contribute enthusiastically. After I wrote a short article, my wife asked me to polish her article. As a result, both of them were published in the peak newspaper. One of the poems won the second prize. To be honest, there was really a little sense of accomplishment at that time. I purposely took those two issues of "Spike Newspaper" home, which I still collect today.
was encouraged to submit articles for the first time. Later, I recorded all the favorite things in the company or some personal thoughts. I wrote some unorganized essays to express my thoughts and understandings, and occasionally appeared in the "Peak News. After my own words were published in the newspapers, I felt that my thoughts had been told between heaven and earth, and I was extremely carefree.
Although the writing skills are very poor, the "Peak Newspaper" has become a platform for me to talk to myself.
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31